C2V is specialized in OEM handheld analytical instrumentation, MEMS product development & foundry services and software tools for the design of microsystem and photonic devices. C2V's micro and nanotechnology combined with their micro GC technology platform plays an important role in enabling new capabilities for LAB analysis via improvement in separation methods, detectors, level of integration and reduction of costs.
Cadence delivers application specific kits and new-generation platforms of integrated design technologies and methodologies that help users address all aspects of electronics design in the nanometer era.
CalciTech has developed a new and patented process for the upcycling of industrial waste lime into Synthetic Calcium Carbonate with the ability to to tailor make products in a wide range of crystal sizes, from nano-sized product (< 0.1micron) up to 20 micron.
California Lithium Battery applies a new Argonne patented process to embed nano-silicon into graphene that Argonne tests show help to stabilize the silicon to create a superior lithium battery anode material.
A leading provider of cutting-edge technologies enabling researchers in the life sciences to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper has compiled numerous best-in-class solutions and is aggressively innovating new technologies to bridge the gaps that exist in bringing in vitro assays to in vivo results and ultimately into cures for human disease.
Cambridge Innovation Consulting Ltd (CamIn) delivers commercialisation solutions for the most cutting edge nano-enabled technologies. Drawing on a broad range of expertise in nanotechnology, CamIn aims to create partnerships with anyone looking to turn their research into real innovation.
Cambridge Nanotherm Ltd, was established in 2010 to commercialise proprietary nano-ceramic technology for use in the electronic industry. The technology has been developed by internationally renowned scientists who are co-founders of the company.
Camurus specializes in the development of pharmaceuticals based on advanced and effective innovative nanoscale drug delivery systems that optimize the bioavailability and therapeutic performance of a wide range of difficult substances, including: peptides, proteins, and insoluble small molecules.
The main expertise of CAN GmbH is the production of various nanoscaled materials like fluorescent, magnetic and catalytically-active nanocrystals. These products are marketed under the brand CANdots and are dispersible in polar or unpolar media readily available for applications in research and industry.
Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize. The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer.